Alice Zhang Speaking Fee: $20,000 to $30,000
Speaking Fee:
$20,000 to $30,000
Travels From:
NYC - New York City
Travels From:
NYC - New York City
Primary Topic Category:
Science (STEM / STEAM)
Primary Topic Category:
Science (STEM / STEAM)
Secondary Topic Category:
Business & Entrepreneurship
Secondary Topic Category:
Business & Entrepreneurship
Alice Zhang Speaker Profile: At A Glance
Alice Zhang is the CEO and Co-founder of Verge Genomics, a biotech company leveraging artificial intelligence to accelerate drug discovery for neurodegenerative diseases. She has been recognized by Forbes as a "30 Under 30" honoree and by MIT Technology Review as an Innovator Under 35. Alice's pioneering work in AI-driven therapeutics positions her as a leading voice in both the tech and healthcare industries.
Alice Zhang is a trailblazer in the biotech industry, serving as the CEO and Co-founder of Verge Genomics, a company dedicated to using artificial intelligence to revolutionize drug discovery. Verge Genomics focuses on developing treatments for neurodegenerative diseases such as ALS, Parkinson's, and Alzheimer's. Zhang's innovative approach integrates genomic data to create more effective and faster solutions for these challenging diseases.
Before founding Verge Genomics, Alice Zhang was deeply involved in systems biology research at prestigious institutions including the National Cancer Institute, Princeton University, and UCLA. She spent five years in the UCLA-Caltech MD/PhD program, contributing to several significant publications on gene networks involved in neuroregeneration.
Her accomplishments have earned her numerous accolades, including being named to Forbes' "30 Under 30" list and MIT Technology Review's Innovator Under 35. In addition to her scientific endeavors, Alice is an active angel investor and advisor for startups at the intersection of technology and biology, further cementing her role as a key influencer in both fields. Her leadership at Verge Genomics continues to drive forward the potential for AI in healthcare, aiming to bring groundbreaking treatments to patients in need.